{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:29:37Z","timestamp":1780576177882,"version":"3.54.1"},"reference-count":37,"publisher":"American Association for Cancer Research (AACR)","issue":"19","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The efficacy of T cell\u2013based immunotherapy to treat cancer patients remains a challenge partly because of the weak activity toward subdominant tumor antigens (TAg) and to tumors expressing suboptimal TAg levels. Recent reports indicate that Toll-like receptor (TLR) stimulation on T cells can lower the activation threshold. In this study, we examined the antitumor activity and survival of TLR2-MyD88\u2013stimulated CD8 T cells derived from melanoma patients and T-cell receptor transgenic pmel mice. TLR2-stimulated pmel CD8 T cells, but not TLR2\u2212\/\u2212pmel or MyD88\u2212\/\u2212pmel T cells, responded to significantly lower TAg levels and resulted in increased production of effector molecules and cytotoxicity. Wild-type or MyD88\u2212\/\u2212 mice treated with TLR2 ligand and pmel T cells, but not TLR2\u2212\/\u2212pmel or MyD88\u2212\/\u2212pmel T cells, showed tumor regression of an established melanoma tumor. Overexpressing TLR2 in TAg-specific T cells eradicated tumors; four times fewer cells were needed to generate antitumor responses. The enhanced antitumor activity of TLR2-MyD88\u2013stimulated T cells was associated with increased effector function but perhaps more importantly with improved survival of T cells. Activating TLR-MyD88 signals in patient-derived T cells also reduced the activation threshold to several weakly immunogenic TAgs, resulting in increased cytokine production, expansion, and cytotoxicity. These data highlight a previously unappreciated role for activating TLR-MyD88 signals in tumor-reactive T lymphocytes. Cancer Res; 70(19); 7442\u201354. \u00a92010 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-0247","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T20:54:20Z","timestamp":1283288060000},"page":"7442-7454","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Amplifying TLR-MyD88 Signals within Tumor-Specific T Cells Enhances Antitumor Activity to Suboptimal Levels of Weakly Immunogenic Tumor Antigens"],"prefix":"10.1158","volume":"70","author":[{"given":"Degui","family":"Geng","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081University of Maryland Greenebaum Cancer Center and 2Department of Otorhinolaryngology, Baltimore, Maryland; 3Louisiana State University Stanley S. Scott Cancer Center, 4Louisiana State University School of Public Health, and 5Ochsner Cancer, Institute, New Orleans, Louisiana; and 6Division of Hematology\/Department of Medicine, Mayo, Clinic College of Medicine, Rochester, Minnesota"},{"name":"Authors' Affiliations:\u20081University of Maryland Greenebaum Cancer Center and 2Department of Otorhinolaryngology, Baltimore, Maryland; 3Louisiana State University Stanley S. Scott Cancer Center, 4Louisiana State University School of Public Health, and 5Ochsner Cancer, Institute, New Orleans, Louisiana; and 6Division of Hematology\/Department of Medicine, Mayo, Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081University of Maryland Greenebaum Cancer Center and 2Department of Otorhinolaryngology, Baltimore, Maryland; 3Louisiana State University Stanley S. Scott Cancer Center, 4Louisiana State University School of Public Health, and 5Ochsner Cancer, Institute, New Orleans, Louisiana; and 6Division of Hematology\/Department of Medicine, Mayo, Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratika","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081University of Maryland Greenebaum Cancer Center and 2Department of Otorhinolaryngology, Baltimore, Maryland; 3Louisiana State University Stanley S. Scott Cancer Center, 4Louisiana State University School of Public Health, and 5Ochsner Cancer, Institute, New Orleans, Louisiana; and 6Division of Hematology\/Department of Medicine, Mayo, Clinic College of Medicine, Rochester, Minnesota"},{"name":"Authors' Affiliations:\u20081University of Maryland Greenebaum Cancer Center and 2Department of Otorhinolaryngology, Baltimore, Maryland; 3Louisiana State University Stanley S. Scott Cancer Center, 4Louisiana State University School of Public Health, and 5Ochsner Cancer, Institute, New Orleans, Louisiana; and 6Division of Hematology\/Department of Medicine, Mayo, Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cruz","family":"Velasco-Gonzalez","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081University of Maryland Greenebaum Cancer Center and 2Department of Otorhinolaryngology, Baltimore, Maryland; 3Louisiana State University Stanley S. Scott Cancer Center, 4Louisiana State University School of Public Health, and 5Ochsner Cancer, Institute, New Orleans, Louisiana; and 6Division of Hematology\/Department of Medicine, Mayo, Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Riker","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081University of Maryland Greenebaum Cancer Center and 2Department of Otorhinolaryngology, Baltimore, Maryland; 3Louisiana State University Stanley S. Scott Cancer Center, 4Louisiana State University School of Public Health, and 5Ochsner Cancer, Institute, New Orleans, Louisiana; and 6Division of Hematology\/Department of Medicine, Mayo, Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetomir N.","family":"Markovic","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081University of Maryland Greenebaum Cancer Center and 2Department of Otorhinolaryngology, Baltimore, Maryland; 3Louisiana State University Stanley S. Scott Cancer Center, 4Louisiana State University School of Public Health, and 5Ochsner Cancer, Institute, New Orleans, Louisiana; and 6Division of Hematology\/Department of Medicine, Mayo, Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Davila","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081University of Maryland Greenebaum Cancer Center and 2Department of Otorhinolaryngology, Baltimore, Maryland; 3Louisiana State University Stanley S. Scott Cancer Center, 4Louisiana State University School of Public Health, and 5Ochsner Cancer, Institute, New Orleans, Louisiana; and 6Division of Hematology\/Department of Medicine, Mayo, Clinic College of Medicine, Rochester, Minnesota"},{"name":"Authors' Affiliations:\u20081University of Maryland Greenebaum Cancer Center and 2Department of Otorhinolaryngology, Baltimore, Maryland; 3Louisiana State University Stanley S. Scott Cancer Center, 4Louisiana State University School of Public Health, and 5Ochsner Cancer, Institute, New Orleans, Louisiana; and 6Division of Hematology\/Department of Medicine, Mayo, Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2010,9,29]]},"reference":[{"key":"2022061701344550500_bib1","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.4049\/jimmunol.175.9.6169","article-title":"Tumor progression can occur despite the induction of very high levels of self\/tumor antigen-specific CD8+ T cells in patients with melanoma","volume":"175","author":"Rosenberg","year":"2005","journal-title":"J Immunol"},{"key":"2022061701344550500_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.2910500220","article-title":"Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells","volume":"50","author":"Coulie","year":"1992","journal-title":"Int J Cancer"},{"key":"2022061701344550500_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20062319","article-title":"Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation","volume":"204","author":"Ford","year":"2007","journal-title":"J Exp Med"},{"key":"2022061701344550500_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes","volume":"12","author":"Boon","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"2022061701344550500_bib5","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/(SICI)1521-4141(200005)30:5<1458::AID-IMMU1458>3.0.CO;2-2","article-title":"Tracing and characterization of the low-avidity self-specific T cell repertoire","volume":"30","author":"de Visser","year":"2000","journal-title":"Eur J Immunol"},{"key":"2022061701344550500_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.160.2.643","article-title":"Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity","volume":"160","author":"Morgan","year":"1998","journal-title":"J Immunol"},{"key":"2022061701344550500_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-2478(02)00228-6","article-title":"Recognition of pathogen-associated molecular patterns by TLR family","volume":"85","author":"Akira","year":"2003","journal-title":"Immunol Lett"},{"key":"2022061701344550500_bib8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1209::AID-IMMU1209>3.0.CO;2-J","article-title":"CpG-oligodeoxynucleotides costimulate primary T cells in the absence of antigen-presenting cells","volume":"29","author":"Bendigs","year":"1999","journal-title":"Eur J Immunol"},{"key":"2022061701344550500_bib9","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.4049\/jimmunol.175.3.1551","article-title":"Direct stimulation of human T cells via TLR5 and TLR7\/8: flagellin and R-848 up-regulate proliferation and IFN-\u03b3 production by memory CD4+ T cells","volume":"175","author":"Caron","year":"2005","journal-title":"J Immunol"},{"key":"2022061701344550500_bib10","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1073\/pnas.0400171101","article-title":"TLR2 is expressed on activated T cells as a costimulatory receptor","volume":"101","author":"Komai-Koma","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061701344550500_bib11","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1096\/fj.08-108274","article-title":"Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity","volume":"22","author":"Asprodites","year":"2008","journal-title":"FASEB J"},{"key":"2022061701344550500_bib12","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/eji.200636181","article-title":"TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation","volume":"36","author":"Cottalorda","year":"2006","journal-title":"Eur J Immunol"},{"key":"2022061701344550500_bib13","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.4049\/jimmunol.172.10.6065","article-title":"Toll-like receptor ligands directly promote activated CD4+ T cell survival","volume":"172","author":"Gelman","year":"2004","journal-title":"J Immunol"},{"key":"2022061701344550500_bib14","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2007-07-104141","article-title":"TLR9 engagement on CD4 T lymphocytes represses {\u03b3}-radiation-induced apoptosis through activation of checkpoint kinase response elements","volume":"111","author":"Zheng","year":"2008","journal-title":"Blood"},{"key":"2022061701344550500_bib15","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.1074\/jbc.M512525200","article-title":"TLR1- and TLR6-independent recognition of bacterial lipopeptides","volume":"281","author":"Buwitt-Beckmann","year":"2006","journal-title":"J Biol Chem"},{"key":"2022061701344550500_bib16","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/eji.200939627","article-title":"TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-\u03b3 secretion in the absence of Ag","volume":"39","author":"Cottalorda","year":"2009","journal-title":"Eur J Immunol"},{"key":"2022061701344550500_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.188.2.277","article-title":"gp100\/pmel 17 is a murine tumor rejection antigen: induction of \u201cself\u201d-reactive, tumoricidal T cells using high-affinity, altered peptide ligand","volume":"188","author":"Overwijk","year":"1998","journal-title":"J Exp Med"},{"key":"2022061701344550500_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.20031591","article-title":"Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN","volume":"199","author":"Ahonen","year":"2004","journal-title":"J Exp Med"},{"key":"2022061701344550500_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4049\/jimmunol.165.1.539","article-title":"Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide\/protein immunization results in enhanced CTL responses with antitumor activity","volume":"165","author":"Davila","year":"2000","journal-title":"J Immunol"},{"key":"2022061701344550500_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/09680519000060050301","article-title":"Differential roles of TLR2 and TLR4 in the host response to Gram-negative bacteria: lessons from a lipopolysaccharide-deficient mutant of Neisseria meningitidis","volume":"6","author":"Ingalls","year":"2000","journal-title":"J Endotoxin Res"},{"key":"2022061701344550500_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1084\/jem.20050732","article-title":"Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells","volume":"202","author":"Gattinoni","year":"2005","journal-title":"J Exp Med"},{"key":"2022061701344550500_bib22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1073\/pnas.75.1.436","article-title":"Evidence that tumor antigens enhance tumor growth in vivo by interacting with a radiosensitive (suppressor?) cell population","volume":"75","author":"Hellstrom","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061701344550500_bib23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.148.3.799","article-title":"Regression and inhibition of sarcoma growth by interference with a radiosensitive T cell population","volume":"148","author":"Hellstrom","year":"1978","journal-title":"J Exp Med"},{"key":"2022061701344550500_bib24","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1084\/jem.164.5.1652","article-title":"Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells","volume":"164","author":"North","year":"1986","journal-title":"J Exp Med"},{"key":"2022061701344550500_bib25","doi-asserted-by":"crossref","first-page":"17469","DOI":"10.1073\/pnas.0907448106","article-title":"Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity","volume":"106","author":"Hinrichs","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061701344550500_bib26","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1172\/JCI32205","article-title":"Microbial translocation augments the function of adoptively transferred self\/tumor-specific CD8+ T cells via TLR4 signaling","volume":"117","author":"Paulos","year":"2007","journal-title":"J Clin Invest"},{"key":"2022061701344550500_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1","article-title":"Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides","volume":"43","author":"van dH","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2022061701344550500_bib28","doi-asserted-by":"crossref","first-page":"R433","DOI":"10.1186\/ar1212","article-title":"Direct Toll-like receptor 2 mediated costimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease","volume":"6","author":"Sobek","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"2022061701344550500_bib29","doi-asserted-by":"crossref","first-page":"15028","DOI":"10.1074\/jbc.M200497200","article-title":"Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4","volume":"277","author":"Asea","year":"2002","journal-title":"J Biol Chem"},{"key":"2022061701344550500_bib30","doi-asserted-by":"crossref","first-page":"C917","DOI":"10.1152\/ajpcell.00401.2005","article-title":"High mobility group box 1 protein interacts with multiple Toll-like receptors","volume":"290","author":"Park","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"2022061701344550500_bib31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1096\/fj.02-1139fje","article-title":"T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors","volume":"17","author":"Zanin-Zhorov","year":"2003","journal-title":"FASEB J"},{"key":"2022061701344550500_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1099\/vir.0.004960-0","article-title":"T cell intrinsic expression of MyD88 is required for sustained expansion of the virus-specific CD8+ T cell population in LCMV-infected mice","volume":"90","author":"Bartholdy","year":"2009","journal-title":"J Gen Virol"},{"key":"2022061701344550500_bib33","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.4049\/jimmunol.181.6.3804","article-title":"MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection","volume":"181","author":"Rahman","year":"2008","journal-title":"J Immunol"},{"key":"2022061701344550500_bib34","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.4049\/jimmunol.0803682","article-title":"The adaptor molecule MyD88 directly promotes CD8 T-cell responses to vaccinia virus","volume":"182","author":"Zhao","year":"2009","journal-title":"J Immunol"},{"key":"2022061701344550500_bib35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.immuni.2006.08.023","article-title":"The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation","volume":"25","author":"Gelman","year":"2006","journal-title":"Immunity"},{"key":"2022061701344550500_bib36","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1158\/0008-5472.CAN-04-2006","article-title":"Bcl-2 overexpression enhances tumor-specific T cell survival","volume":"65","author":"Charo","year":"2005","journal-title":"Cancer Res"},{"key":"2022061701344550500_bib37","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1490","article-title":"Recent developments in the transcriptional regulation of cytolytic effector cells","volume":"4","author":"Glimcher","year":"2004","journal-title":"Nat Rev Immunol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/19\/7442\/2638711\/7442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/19\/7442\/2638711\/7442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T22:42:11Z","timestamp":1685745731000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/70\/19\/7442\/559720\/Amplifying-TLR-MyD88-Signals-within-Tumor-Specific"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,29]]},"references-count":37,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2010,9,29]]},"published-print":{"date-parts":[[2010,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-0247","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22383909.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6500703","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22383909","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6500703.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,29]]}}}